BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27336467)

  • 1. Inhibition of CPU0213, a Dual Endothelin Receptor Antagonist, on Apoptosis via Nox4-Dependent ROS in HK-2 Cells.
    Li Q; Li J; Shao H; Li XX; Yu F; Xu M
    Cell Physiol Biochem; 2016; 39(1):183-92. PubMed ID: 27336467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nox4 is involved in high glucose-induced apoptosis in renal tubular epithelial cells via Notch pathway.
    Yao M; Gao F; Wang X; Shi Y; Liu S; Duan H
    Mol Med Rep; 2017 Jun; 15(6):4319-4325. PubMed ID: 28487945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normalizing NADPH oxidase contributes to attenuating diabetic nephropathy by the dual endothelin receptor antagonist CPU0213 in rats.
    Xu M; Dai DZ; Dai Y
    Am J Nephrol; 2009; 29(3):252-6. PubMed ID: 18802327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of vascular dysfunction by argirein through inhibiting endothelial cell apoptosis associated with ET-1/Nox4 signal pathway in diabetic rats.
    Su J; An XR; Li Q; Li XX; Cong XD; Xu M
    Sci Rep; 2018 Aug; 8(1):12620. PubMed ID: 30135489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The endothelin receptor antagonist CPU0213 is more effective than aminoguanidine to attenuate isoproterenol-induced vascular abnormality by suppressing overexpression of NADPH oxidase [correction of oxidas], ETA, ETB, and MMP9 in the vasculature.
    Xu J; Li N; Dai DZ; Yu F; Dai Y
    J Cardiovasc Pharmacol; 2008 Jul; 52(1):42-8. PubMed ID: 18594475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoproterenol disperses distribution of NADPH oxidase, MMP-9, and pPKCepsilon in the heart, which are mitigated by endothelin receptor antagonist CPU0213.
    Cheng YS; Dai DZ; Dai Y
    Acta Pharmacol Sin; 2009 Aug; 30(8):1099-106. PubMed ID: 19597524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APX-115A, a pan-NADPH Oxidase Inhibitor, Induces Caspase-dependent Cell Death by Suppressing NOX4-ROS Signaling in EBV-infected Retinal Epithelial Cells.
    Hong SW; Noh MH; Kim YS; Jin DH; Moon SH; Yang JW; Hur DY
    Curr Eye Res; 2020 Sep; 45(9):1136-1143. PubMed ID: 31951764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CPU0213, a novel endothelin receptor antagonist, ameliorates septic renal lesion by suppressing ET system and NF-kappaB in rats.
    He HB; Dai DZ; Dai Y
    Acta Pharmacol Sin; 2006 Sep; 27(9):1213-21. PubMed ID: 16923343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative Stress-Activated NHE1 Is Involved in High Glucose-Induced Apoptosis in Renal Tubular Epithelial Cells.
    Wu Y; Zhang M; Liu R; Zhao C
    Yonsei Med J; 2016 Sep; 57(5):1252-9. PubMed ID: 27401659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salidroside protects renal tubular epithelial cells from hypoxia/reoxygenation injury in vitro.
    Sun Y; Xun L; Jin G; Shi L
    J Pharmacol Sci; 2018 Jun; 137(2):170-176. PubMed ID: 29960844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nox4 has a crucial role in uric acid‑induced oxidative stress and apoptosis in renal tubular cells.
    Li Z; Sheng Y; Liu C; Li K; Huang X; Huang J; Xu K
    Mol Med Rep; 2016 May; 13(5):4343-8. PubMed ID: 27052425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sildenafil improves diabetic vascular activity through suppressing endothelin receptor A, iNOS and NADPH oxidase which is comparable with the endothelin receptor antagonist CPU0213 in STZ-injected rats.
    Luo L; Dai DZ; Cheng YS; Zhang Q; Yuan WJ; Dai Y
    J Pharm Pharmacol; 2011 Jul; 63(7):943-51. PubMed ID: 21635260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NADPH oxidase 4 mediates TGF-β1/Smad signaling pathway induced acute kidney injury in hypoxia.
    Cho S; Yu SL; Kang J; Jeong BY; Lee HY; Park CG; Yu YB; Jin DC; Hwang WM; Yun SR; Song HS; Park MH; Yoon SH
    PLoS One; 2019; 14(7):e0219483. PubMed ID: 31318905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astragalosides IV protected the renal tubular epithelial cells from free fatty acids-induced injury by reducing oxidative stress and apoptosis.
    Chen Q; Su Y; Ju Y; Ma K; Li W; Li W
    Biomed Pharmacother; 2018 Dec; 108():679-686. PubMed ID: 30245468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mTORC2 Signaling Regulates Nox4-Induced Podocyte Depletion in Diabetes.
    Eid S; Boutary S; Braych K; Sabra R; Massaad C; Hamdy A; Rashid A; Moodad S; Block K; Gorin Y; Abboud HE; Eid AA
    Antioxid Redox Signal; 2016 Nov; 25(13):703-719. PubMed ID: 27393154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The NADPH oxidase inhibitor DPI can abolish hypoxia-induced apoptosis of human kidney proximal tubular epithelial cells through Bcl2 up-regulation via ERK activation without ROS reduction.
    Song H; Han IY; Kim Y; Kim YH; Choi IW; Seo SK; Jung SY; Park S; Kang MS
    Life Sci; 2015 Apr; 126():69-75. PubMed ID: 25744050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypercholesterolaemia induces early renal lesions characterized by upregulation of MMP-9 and iNOS and ET(A)R: alleviated by a dual endothelin receptor antagonist CPU0213 and simvastatin.
    Luo L; Zheng YF; Dai Y; Dai DZ
    J Pharm Pharmacol; 2009 Jun; 61(6):775-80. PubMed ID: 19505368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulated endothelin system in diabetic vascular dysfunction and early retinopathy is reversed by CPU0213 and total triterpene acids from Fructus Corni.
    Su W; Dai DZ; Liu HR; Na T; Dai Y
    Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1228-33. PubMed ID: 17973859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liraglutide inhibits autophagy and apoptosis induced by high glucose through GLP-1R in renal tubular epithelial cells.
    Zhao X; Liu G; Shen H; Gao B; Li X; Fu J; Zhou J; Ji Q
    Int J Mol Med; 2015 Mar; 35(3):684-92. PubMed ID: 25573030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of NADPH-oxidase enzyme in the nephroprotective effect of (-)-α-bisabolol on HK2 cells exposed to ischemia - Reoxygenation.
    Sampaio TL; Menezes RRPPB; Lima DB; Costa Silva RA; de Azevedo IEP; Magalhães EP; Marinho MM; Dos Santos RP; Martins AMC
    Eur J Pharmacol; 2019 Jul; 855():1-9. PubMed ID: 31047876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.